Abstract
High throughput screening identified a pyrrolidinone containing acidic functionality as a CCR2 antagonist of modest affinity. We describe initial SAR around this hit, including solution phase parallel synthesis for analog preparation, and we describe identification and characterization of an analog subsequently selected as a viable lead molecule for further optimization.
Keywords: MCP-1, CCR2, Chemokine receptor, Antagonist, Inflammation, Hit to lead
Letters in Drug Design & Discovery
Title: Novel, Acidic CCR2 Receptor Antagonists: From Hit to Lead
Volume: 4 Issue: 3
Author(s): D. Zou, H.-X. Zhai, J. Eckman, P. Higgins, M. Gillard, L. Knerr, S. Carre, P. Pasau, P. Collart and J. Grassi
Affiliation:
Keywords: MCP-1, CCR2, Chemokine receptor, Antagonist, Inflammation, Hit to lead
Abstract: High throughput screening identified a pyrrolidinone containing acidic functionality as a CCR2 antagonist of modest affinity. We describe initial SAR around this hit, including solution phase parallel synthesis for analog preparation, and we describe identification and characterization of an analog subsequently selected as a viable lead molecule for further optimization.
Export Options
About this article
Cite this article as:
Zou D., Zhai H.-X., Eckman J., Higgins P., Gillard M., Knerr L., Carre S., Pasau P., Collart P. and Grassi J., Novel, Acidic CCR2 Receptor Antagonists: From Hit to Lead, Letters in Drug Design & Discovery 2007; 4 (3) . https://dx.doi.org/10.2174/157018007780077381
DOI https://dx.doi.org/10.2174/157018007780077381 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dietary Prevention of Coronary Heart Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Molecular Docking and Study of the Anti-inflammatory Effect of Triterpene and Diarylheptanoid Isolated from <i>Pellacalyx axillaris</i>
Infectious Disorders - Drug Targets Bisphosphonate Anticancer Activity in Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Vascular Stiffness: Measurements, Mechanisms and Implications
Current Vascular Pharmacology Anticoagulant Therapy During Pregnancy for Maternal and Fetal Acquired and Inherited Thrombophilia
Current Medicinal Chemistry The Role of Transforming Growth Factor β1 in the Regulation of Blood Pressure
Current Hypertension Reviews The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19
Current Medicinal Chemistry The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease
Current Drug Targets Integrase Interactor 1 in Health and Disease
Current Protein & Peptide Science Nucleic-Acid Delivery Using Lipid Nanocapsules
Current Pharmaceutical Biotechnology Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
CNS & Neurological Disorders - Drug Targets Inhibition of Ceramide Metabolism Key Enzymes and its Implication in Cell Physiology and Pathology
Current Enzyme Inhibition Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
Current Drug Targets HIVs Evasion of Hosts NK Cell Response and Novel Ways of its Countering and Boosting Anti-HIV Immunity
Current HIV Research RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease
Current Molecular Medicine Contribution of Efflux Pump Activity to the Delivery of Pulmonary Therapeutics
Current Drug Metabolism Secretory Production of Recombinant Proteins in Escherichia coli
Recent Patents on Biotechnology Inhibition of Key Fungal (02) Protein(s) (Aspergillus fumigatus) In-Response to Treatment with Poly-Acid Ligand
Current Proteomics Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus
Anti-Infective Agents Updates of mTOR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry